A human study conducted postmortem in patients affected by ASD and schizophrenia showed increased expression of two markers of neuroinflammation and blood–brain barrier impairment, matrix metallopeptidase 9 (MMP9) and 18 kDa translocator protein (TSPO), in the cerebral cortex [121]. The gene discussed is MMP9; the disease is schizophrenia.